| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.04 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.04 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |